Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans

Diabetes

Volumn 47, Issue 10, 1998, Pages 1613-1618

  Dobbins, Robert L ^a   Chester, Michael W ^a   Daniels, Murphy B ^a   McGarry, J Denis ^a   Stein, Daniel T ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HORMONE RELEASE; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

ADULT; BLOOD GLUCOSE; C-PEPTIDE; FASTING; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HEPARIN; HUMANS; INSULIN; ISLETS OF LANGERHANS; MALE; NIACIN; OBESITY;

EID: 0031683543     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.10.1613     Document Type: Article

References (29)

1. Stein DT, Esser V, Stevenson B, Lane KE, Whiteside JH, Daniels MB, Chen S, McGarry JD: Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat. J Clin Invest 97:2728-2735, 1996
2. Stein DT, Stevenson BE, Chester MW, Basit M, Daniels MB, Turley SD, McGarry JD: The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation. J Clin Invest 100:398-403, 1997
3. Dobbins RL, Chester MW, Stevenson BE, Daniels MB, Stein DT, McGarry JD: A fatty acid-dependent step is critically important for both glucose and non-glucose stimulated insulin secretion. J Clin Invest 101:2370-2376, 1998
4. McGarry JD: What if Minkowski had been ageusic? An alternative angle on diabetes. Science 258:766-774, 1992
5. Boden G: Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 45:3-10, 1996
6. Schalch DS, Kipnis DM: Abnormalities in carbohydrate tolerance associated with elevated plasma nonesterified fatty acids. J Clin Invest 44:2010-2020, 1965
7. Balasse EO, Ooms HA: Role of plasma free fatty acids in the control of insulin secretion in man. Diabetologia 9:145-151, 1973
8. Boden G, Chen X, Rosner J, Barton M: Effects of 48-h fat infusion on insulin secretion and glucose utilization. Diabetes 44:1239-1242, 1995
9. Fulcher GR, Walker M, Catalano C, Farrar M, Alberti KGMM: Acute metabolic and hormonal responses to the inhibition of lipolysis in non-obese patients with non-insulin dependent (type 2) diabetes mellitus: effects of acipimox. Clin Sci 82:565-571, 1992
10. Fulcher GR, Walker M, Catalano C, Aguis L, Alberti KGMM: Metabolic effects of suppression of nonesterified fatty acid levels with acipimox in obese NIDDM subjects. Diabetes 41:1400-1408, 1992
11. Fery F, Plat L, Melot C, Balasse EO: Role of fat derived substrates in the regulation of gluconeogenesis during fasting. Am J Physiol 270:E822-E830, 1996
12. Nuutila P, Knuuti MJ, Raitakari M, Ruotsalainen U, Teras M, Voipio-Pulkki LM, Haaparanta M, Solin O, Wegelius U, Yki-Jarvinen H: Effect of antilipolysis on heart and skeletal muscle glucose uptake in overnight fasted humans. Am J Physiol 267:E941-E946, 1994
13. Puhakainen I, Yki-Jarvinen H: Inhibition of lipolysis decreases lipid oxidation and gluconeogenesis from lactate but not fasting hyperglycemia or total hepatic glucose production in NIDDM. Diabetes 42:1694-1099, 1993
14. Dobbins RL, Stein DT: Compatibility of sodium citrate anticoagulation with short- and long-term glucose monitoring (Abstract). Diabetes 46 (Suppl. 1):367A, 1997
15. Landau C, Chen YD, Skowronski R, Hollenbeck CB, Jaspan JB, Reaven GM: Effect of nicotinic acid on plasma glucose concentrations in normal individuals. Horm Metab Res 24:424-428, 1992
16. McGarry JD, Guest MJ, Foster DW: Ketone body metabolism in the ketosis of starvation and alloxan diabetes. J Biol Chem 245:4382-4390, 1970
17. Peiris AN, Mueller RA, Smith GA, Struve MF, Kissebah AH: Splanchnic insulin metabolism in obesity: influence of body fat distribution. J Clin Invest 78:1648-1657, 1986
18. Crespin SR, Greenough WB, Steinberg D: Stimulation of insulin secretion by long-chain free fatty acids: a direct pancreatic effect. J Clin Invest 52:1979-1984, 1973
19. Phillips DIW, Caddy S, Ilic V, Fielding BA, Frayn KN, Borthwick AC, Taylor R: Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism 45:947-950, 1996
20. Stein DS, Dobbins R, Szczepaniak L, Malloy C, McGarry JD: Skeletal muscle triglyceride stores are increased in insulin resistance (Abstract). Diabetes 46 (Suppl. 1):23A, 1997
21. Roust LR, Jensen MD: Postprandial free fatty acid kinetics are abnormal in upper body obesity. Diabetes 42:1567-1573, 1993
22. Koyama K, Chen G, Lee Y, Unger RH: Tissue triglycerides, insulin resistance, and insulin production: implications for hyperinsulinemia of obesity. Am J Physiol 273:E708-E713, 1997
23. Prentki M, Corkey BE: Are the β-cell signaling molecules malonyl-CoA and cytosolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM? Diabetes 45:27:3-283, 1996
24. Kruszynska YT, Mulford MI, Yu JG, Armstrong DA, Olefsky JM: Effects of nonesterified fatty acids on glucose metabolism after glucose ingestion. Diabetes 46:1586-1593, 1997
25. Paolisso G, Gambardella A, Amato L, Tortoriello R, D'Amore A, Varricchio M, D'Onofrio F: Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects. Diabetologia 38:1295-1299, 1995
26. Lee Y, Hiroshi H, Ohneda M, Johnson JH, McGarry JD, Unger RH: β-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-β-cell relationships. Proc Natl Acad Sci U S A 91:1078-1082, 1994
27. Zhou Y-P, Grill VE: Long term exposure to fatty acids and ketones inhibits β-cell function in human pancreatic islets of Langerhans. Clin Endocrinol Metab 80:1584-1590, 1995
28. Unger RH: Lipotoxicity in the pathogenesis of obesity-dependent NIDDM: genetic and clinical implications. Diabetes 44:863-870, 1995
29. Man Z-W, Zhu M, Noma Y, Toide K, Sato T, Asahi Y, Hirashima T, Mori S, Kawano K, Mizuno A, Sano T, Shima K: Impaired β-cell function and deposition of fat droplets in the pancreas as a consequence of hypertriglyceridemia in OLETF rat, a model of spontaneous NIDDM. Diabetes 46:1718-1724, 1997